Drug Diversion in Healthcare is a National Problem, but Recent Survey Shows a Promising Path Forward
Healthcare organizations can lower their risk of drug diversion by strengthening staffing, employee training, and technology.
Tom Knight
Advertisement
Articles by Tom Knight
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
2
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
5
